Anavex Life Sciences Corp (AVXL)

[dia76ca]

And we can expect at least half a dozen significant news items in the next weeks or next month in addition to more granular CTAD data.
! Data of 48-week OLE PDD Phase 2 study – expected by end 2022
! EXCELLENCE completion: Potentially pivotal Phase 2/3 pediatric RTT clinical trial – expected by end 2022
! Initiation of ANAVEX®2-73 imaging-focused Parkinson’s disease clinical trial – expected 2022
! Initiation of potentially pivotal ANAVEX®2-73 Phase 2/3 Fragile X clinical trial – expected 2022
! Initiation of potentially pivotal ANAVEX®2-73 Phase 2/3 clinical trial for the treatment of a new, rare disease
indication – expected 2022
! Initiation of ANAVEX®3-71 Phase 2 clinical trial for FTD, schizophrenias and Alzheimer’s disease –
expected 2022